Skip to content

Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA)

Effect of the Injection of Local Analgesia With Epinephrine During Total Hip Arthroplasty on the Blood Losses Per and Operatively.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00980616
Enrollment
150
Registered
2009-09-21
Start date
2009-09-30
Completion date
2012-03-31
Last updated
2012-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip

Keywords

Arthroplasty, hip, blood losses, pain, local analgesia, epinephrine, Primary total hip arthroplasty

Brief summary

The aim is to determine if the use of infiltration with an adrenalin solution in the operative field of Total Hip Arthroplasty (THA), allays a significant reduction of the cumulated volume of bleeding (pre and post operative) without increasing the per and post operative risks. At the same time, the effect on the post operational pains is evaluated.

Detailed description

This prospective randomized study compares a population receiving a local anaesthetic (ropivacaine, adrenalin and physiological serum) in the operative field to a population undergoing a standard protocol. The cumulated volume of bleeding per and post operative are recorded and complete blood count (CBC).

Interventions

DRUGropivacaine, physical serum and adrenalin

A: experimental group: 235 mg of ropivacaine, 5 ml physical serum and 0.5 mg of adrenalin

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Primary total hip arthroplasty * Age between 50 and 85

Exclusion criteria

* fracture of the femoral neck * patients with contraindications for local anaesthesia

Design outcomes

Primary

MeasureTime frame
measuring volume of cumulated bleeding per and post operative and analyse of complete blood count (CBC)pre and post operative

Secondary

MeasureTime frame
Womac score pre operative, at 3 months and at 12 monthsat 3 months and 12 months
Visual analogue pain score (VAS) during hospitalisationat 3 months and 12 months
Consumption of analgesicsat 3 months and 12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026